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ABSTRACT 
 
 
Stem cell research is revolutionizing the way we look at medicine. The potential 
for stem cells is bound only by our ability to understand their functions. Stem cells could 
be used for the treatment of many diseases and disabilities, which do not currently have 
treatments.  Unfortunately, research within the United States has been stifled due to 
controversy over the derivation of embryonic stem cell lines and embryonic germ lines.  
If stem cell research is to fulfill its potential our legislative policies need to change. 
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EXECUTIVE SUMMARY 
 
  
Stem cell research seeks to revolutionize the way the world understands human 
development, and to develop a new means for regenerating diseased tissues.  Diseases 
and disabilities, for which there may be no current treatment, will have hope. This project 
examined the sources, applications, ethics, and laws pertaining to stem cells.  
 Chapter 1 discusses the types of stem cells and their sources.  Embryonic stem 
(ES) cells are the inner cell mass of a blastocyst (a day 5 human embryo).  In order to 
harvest these cells it is usually necessary to destroy an embryo, which is why ES cell 
research has been the focus of the ethical debate on stem cells.  ES cells hold the most 
medical potential since they can differentiate into a variety of tissues, allowing us to 
manipulate or replace diseased cells.  Embryonic germ (EG) cells are derived from the 
tissue of aborted fetuses, a stage well after blastocyst formation, thus ethicists oppose 
their use even stronger than ES cells. The opposition to abortion in general has lead EG 
cell research into overwhelming controversy.  The cells the public is most unaware of are 
adult stem cells.  These cells come from adult tissues, so for example neuronal stem cells 
might be used to cure a brain neurodegenerative disease.  Because they come from adults, 
and do not require the destruction of an embryo, they are less prone to ethical opposition. 
Such cells include hematopoietic stem cells found in the bone marrow, mesenchymal 
stem cells that can potentially differentiate into a number of connective tissue types, 
intestinal stem cells, stem cells found for the skin, liver and neuronal stem cells.  A newer 
method of obtaining embryonic stem cells is through the use of parthenotes.  A 
parthenote is a term used to describe an egg, embryo, or organism produced without 
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fertilization.  Such embryos can be used to provide ES cell lines, so in the future might 
serve as an alternative source for ES cells.  Mammalian parthenotes cannot divide beyond 
the blastocyst stage, so they have less moral status than blastocysts derived from 
fertilized eggs (which can grow to adults).     
Chapter 2 discusses research applications for the different types of stem cells.   
Many diseases result from the death or dysfunction of one or more types of cells.  
Replacing dying cells by utilizing stem cells’ ability to differentiate into a variety of cells 
could offer more effective treatments or even cures.   Most ES and EG research has been 
performed on animals, human clinical trials with ES cells are only recently underway.  
However adult stem cells have already been used to save thousands of lives.  Adult stem 
cells have been used for over thirty years in bone marrow transplants.  Adult stem cells 
offer an alternative with less of an ethical debate surrounding their application.  Recent 
studies show some success using adult stem cells in the treatment of Parkinson’s, 
diabetes, and heart conditions.  New research on ES and EG cells could aid in the 
identification of events that occur during normal human development, which might lead 
to a better understanding of birth defects and other conditions due to abnormal cell 
specialization and cell division.  But the ethical debate surrounding the clinical 
applications of ES and EG cells has severely hindered progress.   
 Chapter 3 discusses the ongoing ethical debate over stem cells. As with any new 
technology there is a cloud of questions surrounding how we conduct research and how 
we use this new technology.  Embryonic stem (ES) cell and embryonic germ (EG) cell 
research have been the main focus of the ethical debates surrounding stem cell research, 
most religions already support the use of adult stem cells. The source of ES and EG cells 
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have been a particularly hot topic on the debates. Because there is a necessity to derive 
these types of cells from embryos or from aborted fetuses there is great concern as to 
whether it is ethical to use this type of research.  This project closely examined the ethics 
of stem cell research from multiple religious and social points of view. 
 Chapter 4 covers the legislation enforced on stem cell research in the United 
States and the rest of the world.  In August of 2001 President Bush made the decision to 
ban all federal funding for embryonic research using any ES cell lines derived after 
August 2001. This decision would prove to cripple the United States in its research on 
stem cells.  Other countries such as Sweden, Israel, South Korea, and others have all 
ruled for the use of embryos in stem cell research, setting them ahead of the United 
States.    
 In conclusion, our project has taken a close look at everything involved with stem 
cell research. From our research we have concluded that stem cell research will 
eventually revolutionize health care and will create hope for otherwise hopeless victims 
of debilitating diseases. With this we have also concluded that if the United States does 
not change its policy regarding federal funding of ES and EG cell research, we will not 
be able to really participate or contribute in this world changing research. 
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PROJECT OBJECTIVE 
 
 
The purpose of our project was to become educated in the technical aspects, 
applications, ethics, and legalities of stem cell research to understand the various kinds of 
stem cells, where we get them, and their impact on society.  The outcome of the project is 
a paper reporting our findings, and the authors conclusions on key topics formulated by 
the research performed. 
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CHAPTER 1:  STEM CELL TYPES AND SOURCES 
 
 
 Stem cells may be one of the most controversial and misunderstood topics today.   
The public often denounces the use of stem cells yet does not realize the many types and 
current applications of stem cells.  Obtaining adult stem cells does not involve the 
destruction of an embryo.  The public often associates stem cell research only with 
futuristic promises but in the past thirty years, thousands of lives have been saved by 
bone marrow transplants in which the live-saving component is adult hematopoietic stem 
cells.  This chapter will explain what stem cells are, the types of stem cells and how we 
obtain them. 
 
WHAT IS A STEM CELL? 
A stem cell is a cell that is able to divide for indefinite periods of time in culture.  
Upon division, the cell can replicate creating more stem cells (Figure-1, path A), or can 
produce a variety of specialized cells found in the body (Figure-1, path B).  A unique 
characteristic, stem cells divide indefinitely, either renewing themselves and/or producing 
differentiated progeny (NIH, May 2000).   The defective cells in the body can be replaced 
using stem cells since they have the potential to make a variety of tissues.  For example, 
stem cells could be used to replace the faulty brain cells in a patient suffering from 
Huntington’s disease or the heart cells following a heart attack. 
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Figure 1.  The Basic Maturation Path of Stem Cells 
(Harvard Stem Cell Institute, 2005). 
 
STEM CELL CLASSIFICATION 
 One way to categorize stem cells is on the basis of their potential to form other 
cells.  Newly fertilized eggs are totipotent, meaning they can differentiate into any cell 
found within the body. The blastocyst, a hollow ball of cells, is formed by day five or six 
as the fertilized egg divides.  The inner cell mass of this blastocyst contains embryonic 
stem (ES) cells.  These cells are pluripotent, meaning they can make a variety of tissues, 
but are not totipotent.  ES cells have more medical applications than other types of stem 
cells because of their unique ability to make a variety of tissues.  Unfortunately, to obtain 
ES cells, we must usually destroy an embryo.  Two other types of stem cells are 
multipotent and unipotent stem cells. Multipotent stem cells have the ability to make 
several other kinds of one type of tissue; for example, hematopoietic (blood forming) 
stem cells (HSCs) have the ability to make several kinds of white and red blood cells, and 
platelets.  Unipotent stem cells have the ability to make only one kind of cell, usually the 
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same as the tissue they were isolated from.  For example neuronal stem cells have the 
ability to make other neuronal cells. 
 Stem cells are also classified by whether they are isolated from embryos or adults.  
ES cells are usually obtained from aborted embryos.  Adult stem cells are found within 
children and adults.  They can produce cells to maintain our bodies, such as 
hematopoietic stem cells, neuronal (found in brain tissue) stem cells, and epithelial stem 
cells. 
 
Embryonic Stem Cells and Embryonic Germ Cells 
 Embryonic stem (ES) cells are best described in the context of human 
development.  Human development begins when a sperm from a male fertilizes an egg 
from a female.  The resulting cell has the potential to form an entire organism. Within 
hours of fertilization, the single totipotent cell divides into two totipotent cells.  If either 
can attach to the woman’s uterus, a fetus could develop.  Approximately four days later, 
after numerous cell divisions, the cells begin to specialize forming a blastocyst.  A 
blastocyst is a small hollow sphere. The inner cell mass, composed of pluripotent ES 
cells, goes on to develop all of the tissues of the human body.  
In 1998 at the University of Wisconsin, Dr. James Thompson developed a 
technique to isolate and grow the human embryonic stem cells (hESC) (Thompson, 
1998).  This research was conducted without federal funding because of the ban that 
prevented public funding of human embryo research Congress imposed in 1995.   The 
technique involved using embryos from in vitro fertilization clinics, which were in excess 
of the clinical need.  These extra embryos were created for the purpose of reproduction, 
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not research.  Couples with extra embryos were informed of the research and consented.  
Dr. Thompson isolated the inner cell mass of human embryos at the blastocyst stage, and 
fed it growth factors secreted from a “feeder layer” of mouse cells.  Putting the mass in 
culture eventually resulted in a pluripotent ES cell line.  Similar ES cells from mice could 
be used to create dopamine-secreting cells for Parkinson’s patients (Figure-2, path A) or 
insulin-secreting cells for diabetic patients (Figure-2, path B). 
 
 
Figure 2. Directed Differentiation of Mouse Embryonic Stem Cells  
(NIH Stem Cell Basics-3, 2005). 
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Embryonic germ (EG) cells are cells found in early fetal tissue in an area called 
the gonadal ridge, the region of the fetus destined for testes or ovaries.   EG cells are 
approximately five to nine weeks further along in development compared to only five 
days with ES cells, thus EG cells are obtained from a more mature fetus, and have strong 
ethical constraints in their use.  The isolation and successful culture of EG cells was first 
reported in 1998 by Dr. Gearhart.  Using aborted fetuses, Dr. Gearhart took cells from the 
gonadal ridge, and cultured them to produce a pluripotent EG stem cell line.   Figure-3 
contrasts ES and EG cells. 
 
 
  Figure 3.  ES Cells versus EG Cells (NIH SCI Report, 2005). 
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Adult Stem Cells 
 Adult stem cells are obtained from adult organisms, not from embryos or fetuses, 
so they hold much promise for future research as replacements for ES cells.  Adult stem 
cells have been isolated in a number of organs including bone marrow, umbilical cord, 
brain, and skin, in rodents, nonhuman primates, and humans.  Recent studies suggest that 
a variety of tissues in adult animals and humans may harbor adult stem cells.  This means 
that in our bodies, there are cells that can produce cells we need to maintain our bodies.  
Most adult stem cells are unipotent and, therefore, only able to make the same type of cell 
as the tissue they were derived from. Hematopoietic stem cells (HSCs) are multipotent 
and able to make the various cellular components of blood (Figure-4).  For over thirty 
years, HSCs have been used in bone marrow transplants to save thousands of lives.  
Chemotherapy and radiation therapy destroys blood forming cells as well as cancer cells.  
HSCs are used to reconstitute blood following theses therapies so new cells can produce 
healthy blood forming cells. 
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Figure 4.  Hematopoietic and Stromal Stem Cell Differentiatio (NIH Stem Cell Basics-4, 
2005). 
Since no embryo is destroyed to obtain adult stem cells, there is less of an ethical 
debate surrounding that research.  In fact as discussed in Chapter 3, all four major 
religions support the use of adult stem cells.  But although adult stem cells and EG cells 
offer medical promise, they have some disadvantages.   Adult stem cells have not been 
isolated for all of the tissues in the body.  No cardiac or pancreatic islet stem cells have 
been found yet.  Adult stem cells are often present in small quantities, quantities may 
decrease with age, and are they are difficult to isolate and purify.   EG cells are also 
present in small quantities, so the feasibility of large scale sourcing and manufacturing is 
limited.  Also, research on EG cells has been halted because of the ethical issues 
concerning abortion and the destruction of human tissue while obtaining EG cells.   
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Because of these negatives for adult and EG cells, pubic debate on the use of ES cells 
must still continue. 
 
Parthenotes   
A parthenote is a term used to describe an egg, embryo, or organism produced 
without fertilization.  In nature, only some insects, reptiles, aphids, and turkeys are 
capable of this process.  For example, bees and ants produce their “workers” via 
parthenogenesis.   Female reptiles, including some other animals, are able to produce 
offspring without fertilization from a male sperm.  During this process, called 
parthenogenesis, female eggs divide, developing into embryos and eventually offspring.   
In the lab, parthenotes can be created from monkeys and humans using 
chemically treated eggs that begin dividing without fusing with a sperm. Using chemicals 
that mimic the sperms arrival, scientists have been able to obtain parthenote blastocysts 
from monkey (Cibelli et al, 2002) and man (Cibelli et al, 2001), although ES cell lines 
have only been derived from monkey parthenotes so far (Cibelli et al, 2002; Kiessling, 
2005).  The mammalian parthenotes created in a lab cannot make entire organisms 
because they cannot grow beyond the blastocyst stage.  This is because producing a 
normally developing embryo requires an egg from a female that is fertilized by a sperm 
from a male in mammals.  When a sole egg is stimulated to divide on its own, the 
resulting parthenote can only survive early stages of development before it is naturally 
terminated.     
Mammalian embryo blastocyst parthenotes may have the potential to produce ES 
cells.  Because mammalian parthenotes cannot divide beyond the blastocyst stage, they 
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have less moral status than blastocysts derived from fertilized eggs (which can grow to 
adults).  So the recent excitement about parthenotes is focused on their potential as an 
alternative source of ES cells without using fertilized eggs, the latter of which some 
characterize as murder.  Monkey parthenotes have successfully produced stem cells 
which have developed into intestine, skeletal muscles, retina, hair follicles, cartilage, 
bone, nerve cells and heart cells that beat in unison (Weiss, 2001).   
There are some major technical problems surrounding parthenogenesis in humans.  
First, scientists do not know whether these cells are dangerously inbred.  Normal 
development requires both male and female chromosomes, found in the sperm and the 
egg.  Due to the use of only one set of chromosomes, stem cells from this process may 
uncontrollably divide, like tumor cells.  Second, viable eggs are very difficult to obtain 
from postmenopausal women.  Unfortunately, these are the women who most likely will 
suffer from a degenerative disease and need the stem cell treatment.  Third, 
parthenogenesis does not produce a normally developing embryo.  Although the 
parthenote will naturally terminate itself, federal law still considers it an embryo (Weiss, 
2001). 
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CHAPTER 2:  STEM CELL APPLICATIONS 
 The cost and psychological tolls of chronic, degenerative and acute disease in the 
United States are enormous.  For example, in the United States alone, the total cost of 
treating diabetes is approaching $100 billion (http://www.diabetes.org/ada/c20f.asp).  The 
public may have some confusion over stem cells chances for success in the treatment of 
degenerative conditions, which afflict 128 million people in the United States (Chapman, 
A. 1999). Actual human lives have been saved by stem cells.  The progress scientists 
have made using animals supports the use of stem cells as a treatment for a variety of 
diseases.  In this chapter we will present the work that has been performed with stem 
cells as well as some future applications.   
 
POTENTIAL APPLICATIONS OF PLURIPOTENT STEM CELLS 
USES FOR RESEARCH 
There are many reasons that the isolation of human pluripotent stem cells is 
important.  The complex events that occur during normal human development could be 
further understood.  Cancer, birth defects and other conditions are due to abnormal cell 
specialization and cell division.  Understanding the mechanisms behind these serious 
medical conditions requires the identification of factors involved in the cellular decision 
making process that result in cell specialization.   Many diseases result from the death or 
dysfunction of one or more types of cells.  Replacing dying cells by utilizing stem cells 
ability to differentiate into a variety of cells could offer more effective treatments or even 
cures.   The most promising research involves diseases of the nervous system.  For 
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example, Alzheimer’s disease is associated with the dysfunction of the cells that make 
acetylcholine, a neurotransmitter particularly important in muscle stimulation.   
Huntington’s disease is connected with cells that make gamma aminobutyric acid, also a 
neurotransmitter that blocks nerve impulses.  Possibly the most well known examples are 
amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. ALS is linked to motor 
nerve cells that activate muscles and Parkinson’s is related to the cells that produce 
dopamine.   
 The most far-reaching potential application of human pluripotent stem cells is the 
generation of cells and tissues for cell therapies.  Currently, donated organs and tissues 
are the most commonly used way to replace ailing or destroyed tissues.  Unfortunately, 
donations are limited.  There simply is not enough to go around.  Stimulating pluripotent 
stem cells to develop into specialized tissues offers possible treatment to suffering 
patients.  This method could be used to treat a myriad of diseases and conditions 
including Parkinson’s disease, Alzheimer’s disease, spinal cord injury, stroke, burns, 
heart disease, diabetes, osteoarthritis, and rheumatoid arthritis.  Treating a diseased heart 
with healthy heart muscle cells, grown from pluripotent stem cells, has shown promise in 
mice.  After transplanting the healthy cells into a diseased heart, the new cells 
repopulated the heart with healthy cells and beat in unison with the host cells. 
A major problem with organ transplantation is rejection.  Somatic cell nuclear 
transfer (SCNT) offers the possibility of developing cells from the patient.   This process 
involves replacing the nucleus of an unfertilized egg cell with the nucleus from a somatic 
cell (for example a skin, heart or nerve cell) (www.aamc.org).   The unfertilized egg cell 
with replaced nucleus is then stimulated to divide.  Once the cell begins dividing, stem 
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cells can be extracted five to six days later.   These new stem cells can go on to develop 
into a variety of replaceable organs and tissues.  The patient need not fear the possibility 
of rejecting the transplant because it came from the patient’s own cells.   Another method 
being testing to produce immunologically compatible cells involve the major 
histocompatibility complex (MHC).  The MHC is a large cluster of genes essential to the 
human immune system.  The MHC genes encode human leukocyte antigens (HLA).  
HLAs are proteins displayed on the cell surface, which define a person’s tissue type.  If 
foreign HLAs are detected, then the cells or tissue displaying them are destroyed.  This is 
why the body rejects grafts and transplants from donors without a matched tissue type.  
Using stem cell technology would give doctors a method of ensuring the transplant is not 
rejected.   
Drug development could also be improved using pluripotent stem cells.  Instead of 
testing new drugs entirely on animals, the drugs could be tested on human cell lines, 
resulting in more accurate and effective medicines.  The benefits and toxic effects of 
biologicals, chemicals, and drugs could be tested on human pluripotent stem cell lines.  
For example, cancer cell lines can be used to screen potential anti-tumor drugs. If 
pluripotent stem cells were more accessible, many more drugs could be tested on a wider 
variety of cell types.  The current problem lies in the required testing conditions.  To be 
effective, scientists must create identical testing conditions when comparing different 
drugs.  Currently, scientists have limited knowledge and ability to control the 
differentiation of stem cells into the particular cell type needed for testing.  Since the 
biological signals controlling differentiation are not completely known or understood, it 
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would be extremely difficult to mimic conditions precisely and consistently for each drug 
tested. 
THE TREATMENT OF DISEASES USING EMBRYONIC STEM CELLS 
Neural Stem Cells:  ALS and Parkinson’s Disease. 
ALS, also known as Lou Gehrig’s disease, is a neurodegenerative disease, 
attacking the upper and lower motor neurons and deteriorating the brain and spinal cord. 
The upper motor neuron symptoms include spasms, rigidity and abnormal reflexes while 
the lower motor neuron symptoms include weakness and atrophy.  A very common 
symptom is weakness in a hand, foot, or leg.  Sufferers generally die from this disease 
within two to six years of diagnosis.  Unfortunately the biological mechanisms that cause 
ALS are only partially understood.  The only known cause is a mutation in a specific 
gene (SOD1 gene), which contributes to the number of inherited cases (www.als.org).  
This mutation results in the production of a defective protein that kills motor nerve cells.  
Only 5 to 10 percent of all reported ALS cases are familial cases.  All other cases usually 
arise suddenly in normally healthy people.   
In July of 2001, researchers from John Hopkins University released a tape that 
proves that stem cells hold much promise.  The tape shows 120 mice and rats paralyzed 
by a motor neuron disease similar to ALS.  Once the mice showed signs of motor neuron 
degeneration similar to that seen in patients with ALS, fluid containing human embryonic 
stem cells was infused into the rodent’s spinal cord.  All 120 showed signs of 
improvement and some ability to move.  Some even regained movement of their 
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extremities, were able to bear their own weight and move around after being treated with 
embryonic stem cells (Kay, 2001).   
Parkinson’s disease affects the cells that produce dopamine in the brain.  
Dopamine, a hormone-like substance, is an essential neurotransmitter.   Imbalanced 
amounts of dopamine can cause brain diseases and dysfunctions.  It is critical to how our 
brains control our movements.  Parkinson’s disease is caused by the death of a group of 
dopamine-producing neurons in the substantia nigra.  This causes low levels of dopamine 
to be secreted, resulting in the characteristic jerky, uncontrolled movements.    
Parkinson’s disease affects about two-percent of the population over age seventy.   
Symptoms include slow and stiff movements, problems with balance and walking, and 
tremors.  Stooped posture, a short shuffling pace, falling, and incontinence can be seen in 
advanced cases of Parkinson’s.  The current treatment for Parkinson’s disease is a drug 
called Levodopa (L-dopa), which is converted to dopamine in the brain.  This can 
alleviate the associated symptoms for some.  However, as the neurons continue to die, the 
drug’s effectiveness decreases.   
Parkinson’s disease is a logical candidate for cell replacement therapy because 
conventional treatments have had limited success.  Researchers have had some success 
treating patients by grafting immature neurons from aborted human fetuses into the 
affected region.   Many patients who undergo this experimental procedure have up to a 
fifty- percent reduction in symptoms and continue to benefit years after the grafts were 
implanted.  The success of this surgery depends on the survivability of the implanted 
neurons and making functional connections at the appropriate locations within the brain 
(Dunnett, 2001).  Clearly the mechanism that killed the patient’s original cells is not 
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killing the new cells.   Researchers can now measure the amount of dopamine being 
produced using Positron Emission Tomography (PET) images.  Figure 5 compares the 
production of dopamine (bright white in the diagram) before (top) transplantation of the 
grafts and after (bottom).   
 
 
Before Surgery 
 
 
After Surgery 
 
Figure 5.  PET Images of Dopamine Levels Following Dopamine-Neuron 
Transplantation.  Dopamine appears as bright white  (NIH SCI Report, 2001). 
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 In 1990, the National Institutes of Health funded two double-blind clinical trials 
of fetal tissue implantation.  Neither the patient nor the researcher knew who would 
receive the experimental treatment.  Half of the patients underwent a sham surgery and 
the other half had fetal tissue implanted into their brain.   Patients who received the 
implants showed no significant improvement (Freed, 2001).  However, PET scans and 
autopsies of patients who received the implants proved that some of the dopamine 
neurons survived and grew.   
The problem with treating Parkinson’s patients with embryonic stem cells lies in 
quantity.  It takes approximately six fetuses to provide the stem cells needed to treat one 
Parkinson’s patient.  There will always be more patients suffering than there will be 
replacement tissue.   For this reason, and many others, growing ES cell lines, or adult 
stem cell treatments may be a more feasible approach. 
 
ADULT STEM CELL APPLICATIONS 
 Embryos are not the only source of stem cells.  The public is often unaware that 
some adult tissues contain stem cells.  These adult stem cells are able to regenerate the 
tissue they were isolated from but are not able to generate multiple kinds of tissues like 
ES cells.  They have fewer ethical concerns because their use does not destroy an 
embryo.  In fact, all four major religions support the use of adult stem cells.  The use of 
adult hematopoietic stem cells in bone marrow transplants has paved the way for the 
transplantation of pancreas, skin and brain cells.  Many organs have tissue-specific stem 
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cell populations.  Although only hematopoietic and neural stem cells can currently be 
isolated, it is clear that the isolation of tissue-specific stem cells will enable cell 
replacement therapy.   
 
THE TREATMENT OF DISEASES USING STEM CELLS 
Hematopoietic Stem Cells:  Autoimmune Diseases 
 Hematopoietic Stem Cells (HSCs) primary purpose is to replenish the blood.  
HSCs can be cultured to produce stromal stem cells, which differentiate into cartilage and 
bone.  These cells will help create bone after a bone fractures.  For other thirty years, 
hundreds of thousands of lives have been saved through the use of adult hematopoietic 
stem cells in bone marrow transplants.  Hematopoietic stem cells (HSCs) are the “active” 
component of bone marrow treatments, and these cells create new cellular components of 
blood (white cells, red cells, platelets) in cancer patients following radiation or 
chemotherapy.   
A new topic in HSCs therapy is the isolation of HSCs from umbilical cord 
samples instead of bone marrow.  Mothers can donate the cord at birth, which can then be 
used for research purposes, or for treating family members in the future.  Cord blood 
registries are companies that store umbilical cord blood for a fee.  After the child is born, 
the umbilical cord is specially packaged and then shipped to their holding facility.  There, 
the stem cells in the umbilical cord are frozen in a cryogenic tank at –400 degrees 
Fahrenheit.  Currently, these facilities house over 30,000 samples from families.  The 
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initial cost is $1,300 followed by a storage fee of $95 per year.  Another option is public 
blood banks, which are free and found in major cities, but the abundance of HSCs in 
whole blood is far less than in cord blood.  Cord blood has treated a wide range of 
cancers, genetic diseases, immune system deficiencies and blood disorders (Marin, CBS 
2002). 
HSCs are more abundant in umbilical cord blood than bone marrow, and the cells 
are more primitive so there is less chance of immunorejection (Viacell, 2002).  Blood 
disorders, such as sickle cell anemia have been successfully treated using stem cells 
found in umbilical cords (Marin, 2002). HSCs are injected intravenously and then 
migrate to the bone marrow.  If successful, the HSCs will rebuild a new immune system 
by producing healthy cells to replace diseased blood.  HSCs from cord blood are less 
likely to cause a transplantation complication called graft-versus-host disease, in which 
white blood cells from a donor attack tissues of the recipient. In a recent review of 
umbilical cord blood transplantation, Laughlin cites evidence that cord blood causes less 
graft-versus-host disease  Laughlin writes that it is yet to be determined whether 
umbilical cord blood HSCs are, in fact, longer lived in a transplant recipient.  
Researcheres found that cells from human cord blood had a greater proliferation capacity 
than cells dervived from adult bone marrow.  White blood cells from cord blood 
engrafted better in a mouse model, which was genetically altered to tolerate the human 
cells, than did their adult counterparts. 
Hematopoietic stem cells could also be a promising treatment for autoimmune 
diseases.  Autoimmune diesases occur when the immune system is unable to recognize 
 26 
our own cells from foreign cells in the body.  Our cells begin to attack other necessary 
cells in our body.  This results in tissue destruction and tissue inflammation.  The 
inflammation leads to the development of swollen blood vessels in vasculitis, destruction 
of the joints in rheumatoid arthritis, the destruction of the insulin producing beta cells of 
the pancreas in type 1-diabetes, or damage to the kidneys in lupus.  Autoimmune diseases 
can be organ specific or non-organ-specific.   Type 1 diabetes is an example of an organ-
specific autoimmune disease because pancreatic beta cells are destroyed, which 
contribute to the production of insulin.  The reasons for the failure of the immune system 
are not completely known.  Similarly, multiple sclerosis is caused by the breakdown of 
the protective myelin sheath that covers the nerves.  However, diseases such as lupus are 
characterized by vast injury due to reactions against many organs and tissues.  Genetic 
factors, environmental and hormonal influences, and some infections may contribute to 
tolerance and the development of autoimmune disease (Cooper, 1998).  Current 
treatments for autoimmune diseases include the systemic use of anti-inflammatory drugs 
and potent immunosuppressive agents.  But these treatments have a variety of side effects 
ranging from upset stomach, indigestion, and stomach ulcers. 
 Lupus afflicts mostly African-American and Hispanic women.  This disease 
affects the entire body including muscles, skin, joints, the brain and nerves as well as all 
major organs.   The major problem with treating lupus is the lack of a specific target for 
therapy.  Using hematopoietic stem cells to treat lupus is currently being testing in early 
clinical trials.  The stem cells would destroy the long-lived and auto-reactive immune 
cells and create a properly functioning immune system.  To do this, researchers inject a 
growth factor into the patient.  This growth factor intices large amounts of hematopoietic 
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stem cells to be released from the bone marrow.  These cells are harvested from the blood 
and purified.  The healthy stem cells are stored until a sufficient quantity of them are 
obtained.  The patient is then exposed to chemotherapy or radiation therapy to kill the 
defective cells.   The purified, healthy hematopoietic stem cells are returned to the patient 
via a blood transfusion and then migrate to the bone marrow and begin producing new, 
mature immune cells (Stem Cells: Scientific Progress and Future Research, 2001).    The 
immune system is essentially restored.   However, the long recovery period can put the 
patient at risk for bacterial, fungal and viral infection.   
 Recent studies suggest that this therapy is an effective and long-term treatment for 
lupus.  A follow-up study of seven patients who underwent the treatment conducted one 
to three years later found that they remained free from active lupus.   The patients 
continuously improved after treatment.  Since the adult stem cells came from their own 
body, immunosuppressive drugs were not required (Burt, 2000).   
 
Epidermal Stem Cell Treatments:  Skin Substitutes 
 The skin is the largest organ in the body.  It is also the first line of defense against 
dehydration, injury and infection.  For these reasons, the skin has evolved an elaborate 
differentiation process.  Mammalian skin consists of a dermal and epidermal component.  
The epidermal components contain stem cells and are located outside the base of the hair 
follicle.   
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Figure 6.  The location of epithelial stem cells (Alonso, 2003). 
 
Tissue, or epithelial, stem cells form the cellular base for the development and 
repair of tissues and organs.  These cells are pursued because they have the potential of 
therapeutic reprogramming to grow human tissue in vitro for human disease treatment, 
although they are difficult to identify and characterize.   Mammalian skin epithelium has 
is quickly produced, which becomes more rapid after injury due to burn or wounding. In 
recent years a significant body of work has begun to characterize the skin epithelial stem 
cells, both in tissue culture and in mouse and human skin (Alonso, 2003). 
Skin grafting has already been proved useful in clinical applications because of 
their accessibility and ability to be cultured.  Cultured epithelial stem cells are most 
prominently used to replace skin that has been burned, has chronic open wounds or ulcers 
(Alonso, 2003).    Using the patient’s own cells allows for long-term repopulation of skin.  
Currently, affected areas of skin are replaced with portions of healthy skin.  This method 
id effective but is limited by the surface area of unaffected skin.  Culturing stem cells 
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allows for more of the affected area to be treated however, it takes time, leaving the 
patient with open wounds making them susceptible to infection.  There are other potential 
applications of cultured epithelial stem cells besides replacing damaged skin.  
Researchers are also considering them as delivery instruments for gene therapy (Alonso, 
2003). 
 There are four current skin constructs that are commercially available.  Genzyme 
Tissue Repair is offers a product called Epicel that takes a small sample of the patient’s 
skin and then grows sheets of the same skin in about sixteen days 
(www.genzymebiosurgery.com).   Integra LifeSciences Corporation engineered a wound 
dressing using synthetic collagen and silicon layers.  Organogenesis Corporation’s 
Apligraft is similar to Integra LifeSciences’ skin substitute, however it incorporates 
human fibroblasts (dermal cells), which forces the epidermal cells to multiply causing the 
replication of the human epidermis (www.apligraft.com).   The final skin grafting product 
is Advance Tissue Science’s Transcyte.  This graft uses cultured fibroblasts and nylon 
layers to reproduce the dermis. 
 Scientists are now trying to create skin substitutes that are readily available and 
do not cause rejection of the transplant (autologous transplant).   The best method to 
obtain cultured epithelial autografts is through taking a small biopsy and putting it in 
culture.  The biopsy is done in hairy sites because adult pluripotent stem cells are located 
at the base of the hair follicle (Coulomb, 2002).  Cells are then cultured and placed on the 
patient’s wound to promote healing. 
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Neural Stem Cell Treatments:  Parkinson’s Disease 
Neural stem cell transplantation occurs when there is a loss of brain function.  
Researchers have had some success treating Parkinson’s patients by grafting neurons 
from aborted fetuses into the affected region of the brain.  Many patients who undergo 
this experimental procedure have up to a fifty- percent reduction in symptoms and 
continue to benefit years after the grafts were implanted. However, there neuronal grafts 
are not the only option.  Wesley Smith from the National Review points to a study 
conducted using adult stem cells.  A 49-year-old man was diagnosed with a progressive 
case of Parkinson’s disease.  Drug therapy did not help, so he tried an experimental 
procedure.  Adult stem cells were harvested from the patient’s brain using a standard 
brain biopsy method.  The cells were cultured to several million cells, with twenty- 
percent maturing into dopamine producing neurons.  In March 1999, the cells were 
injected into the man’s brain.  Three months later, the man’s motor skills had improved 
by thirty-nine- percent and the dopamine production was up fifty-five- percent (Smith, 
2002).   
 
Pancreatic Stem Cell Treatments:  Diabetes 
Currently, there are 16 million people suffering from diabetes.  It causes almost 
200,000 each year, more than breast cancer and AIDS combined (www.diabetes.org).  
Diabetes is a group of diseases that are described by abnormally high levels of the sugar 
glucose in the bloodstream.  The excess glucose causes the complications of diabetes, 
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including blindness, kidney failure, stroke, and heart disease.  There are two main types 
of diabetes; type 1 diabetes, known as juvenile-onset diabetes, affects mostly children, 
and young adults and type 2 diabetes, called adult-onset diabetes, affects mostly adults.  
Diabetes develops when the body’s own immune system does not recognize its own islet 
cells and therefore regards them as foreign invaders.   The immune system attacks the 
islet cells of the pancreas, which normally produce insulin.  The absence of insulin 
prevents glucose from entering the cell and glucose accumulates in the blood 
(www.diabetes.org).    
There is currently no cure for diabetes.  People with type 1 diabetes must rely on 
blood glucose concentration monitoring and take insulin shots.  People with type 2 
diabetes can often control their blood glucose concentration with diet, exercise and oral 
medications.  Each year 1,300 people with type 1 diabetes receive whole-organ pancreas 
transplants and 83 percent will have no symptoms of diabetes.  To prevent the body from 
rejecting the transplant, patients must take powerful immunosuppressive drugs for life.  
These drugs mute their immune system, making the patient highly susceptible to 
infections.  Some physicans oppose the transplantions because the infections may be 
more life-threatening than diabetes itself.   
In 2000, researchers announced that ductal cells isolated from adult human 
pancreatic tissue could be induced to produce insulin when exposed to glucose (Bonner-
Weir, 2000).   The hope is that a biopsy may be done to remove duct cells from a patient, 
culture them and give the healthy islets back to the patient.  Both type 1 and type 2 
diabetes could be treated with this therapy.   These results have been confirmed by 
another group of researchers who also cultured cells from pacreatic ducts in humans and 
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mice.  Implanting the cultured cells reversed diabetes in mice (Stem Cells: Scientific 
Progress and Future Research, 2001).    More recent studies suggest that only embryonic 
stem cells are the only cells capable of differentiating in beta cells (Dor, 2004). 
Using adult stem cells to treat diabetes is still in its infancy and  studies using embryonic 
stem cells have had more success.   ES cells are able to generate cell lines that are free of 
contaminants and can self renew, although until a theraputically useful source is 
developed all avenues must be explored.    
 
Cardiac Treatments 
In the United States, it has been estimated that congestive heart failure afflicts 4.8 
million people and there are 400,000 new cases each year (Stem Cells: Scientific 
Progress and Future Research, 2001).  This disease is caused by the destruction of 
cardiomyocytes, the heart’s muscle cells.   Hypertension, cornonary artery disease or a 
heart attack can kill these cells.  Although there have been advances in surgical 
procedures, drug therapy, and organ transplantation the heart remains weak and the 
patient often dies within five years of diagnosis.  Stem cells could offer a cure if damaged 
cardiomytes can be replaced. 
 The cardiomyte is the heart muscle cell that contracts to force the blood out of the 
heart’s pumping chamber, known as the ventricle.  Two additonal specialized cells are 
the vascular endothelial cell and the smooth mucle cell.  The vascular endothelial cell 
forms the lining of new blood vessels and the smooth muscle cell forms the blood vessel 
walls (Stem Cells: Scientific Progress and Future Research, 2001). These two cells 
contribute to the network of arteries responsible for transporting nutrients and oxygen. 
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Figure 7.  Heart Muscle Repair with Adult Stem Cells. (© 2001 Terese Winslow, Lydia Kibiuk) 
 
To test the theory that heart muscles can regenerate if given healthy cells, 
researchers induced heart attacks in a group of mice.  Heart attacks damage the 
cardiomyocytes, vascular endothelium and muscle cells in the heart resulting in severely 
damaged blood vessels.  This damage reduces blood, oxygen and nutrients going into and 
out of the heart.  Following the heart attack, researchers isolated a group of adult bone 
marrow cells in the mice.  These bone marrow cells had the ability to develop into many 
cell types.  These cells formed new cardiomyocytes, vascular endothelium and smooth 
muscle cells when injected into damaged ventricle walls within the heart (Figure 6a).  
New coronary arteries, arterioles, and capillaries were formed, and within nine days 
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occupied 68 percent of the damaged portion.  Essentially, the dead myocardium was 
replaced with functioning tissue. The mice that received the transplant were more likely 
to survive than the mice that did not receive the transplant.  Follow-up experiments are 
now being conducted to extend the posttransplantation analysis time to determine the 
longer-range effects of such therapy (Stem Cells: Scientific Progress and Future 
Research, 2001). 
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CHAPTER 3:  STEM CELL ETHICS 
 
 
 
 
Figure 1 Cartoon by Gary Marsten  
 
 Stem cells have been a controversial topic in ethics ever since they were 
discovered. The major ethical concern plaguing stem cells has been their derivation. 
Embryonic stem (ES) cells are derived from embryos early in their development. 
Embryonic germ (EG) cells are derived from the tissue of aborted fetuses, even later in 
development than ES cells. These two types of stem cells have triggered one of the 
largest ethical debates in the past century.  Many varied social, religious, political and 
ethical viewpoints have fueled this debate.  Another factor contributing to the amount of 
controversy over stem cells is ignorance. People are forming opinions, and making 
ethical and moral judgments without knowing anything about what they are judging. 
Ignorance and misunderstanding have plagued stem cells from the start, with most people 
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assuming all stem cells are alike.  We must be educated about where, how and when stem 
cells can be derived in order to make any opinion on the topic.  
Religion is the starting place for the ethical opposition to stem cell research 
because of its tremendous influence on the general public and, unfortunately, politics. 
The sources of turmoil in the religious part of the debate are the two moral obligations 
instilled upon people by the majority of religions. The first being that we, as humans, 
have the moral obligation to help other people in need.  Promises held in stem cells seek 
to revolutionize worldwide medical care, and start healing people that have no hope at the 
moment. The other moral obligation is that we must not assume the role of creator. In the 
scope of this ideology we do not have the authority to choose life or death for another 
human being. This is where abortion, EG cells, ES cells and stem cell research in general 
collide with religious belief.   
The initial question that rises from this debate is whether it is ethical to destroy an 
embryo or a fetus. Separate from stem cell research, there is currently a large ethical 
battle over the question of whether abortion should be legal.  A question, coupled to the 
last, is when does a fertilized egg become human.  At one end of the spectrum of views 
on the human status of the embryo is the view that, from conception, the embryo is fully 
a person with all the rights any person has, most notably the right to life. At the other end 
of the spectrum stands the view that the early embryo is little more than cellular material 
the size of the dot at the end of this sentence, which demands little, if anything, of us 
morally.  Reductionist views of the fetus are often found, for example, in the writings of 
those whose moral views are shaped by the law.  Consider the work of the well-known 
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and influential legal scholar John Robertson. Although Robertson would probably dispute 
the characterization of his view as the extreme, one that embryos are merely biological 
material, the way he frames his discussion of embryo research and the uses of the 
embryos indicates that his view is extreme.  For Robertson, the real question in the debate 
about embryo research is whether the reproductive freedom that justifies assisted 
reproduction also justifies embryo research. In his book, Children of Choice, Robertson 
tells us that the fundamental question is this: “Does procreative liberty entitle people to 
use their reproductive capacity to produce products or material to serve nonreproductive 
ends?” (Robertson 1994)   Once the question is framed in this way, the only real reason to 
oppose embryo research is that it may involve a kind of symbolic harm to embryos, and 
this harm will almost always be outweighed by the potential benefits of embryo research. 
 
VIEWS OF THE FOUR MAJOR RELIGIONS 
The four major religions in the United States certainly disagree on many issues of 
the embryonic research debate.  One question of religious concern is whether it is even 
ethical to use something that has the potential to be human in research. Should we take 
something that could become a human and use it for the preservation of our society. 
Ethicists say the right and wrong of destroying even unwanted embryos in order to do 
promising medical research depends on what you think those embryos are. If they have 
the moral status of persons, many argue, then they cannot be treated as a means to even 
the most humanitarian end.  If they are other than future persons, then doing the research 
may seem to help the greater good.  
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CATHOLIC 
Catholic view on the status of an embryo is that, from conception, there is human 
life. We see this, for example, in the Instruction Donum Vitae, issued by the Vatican’s 
Congregation for the Doctrine of the Faith (CDF) in 1987 
(http://www.cin.org/vatcong/donumvit.html), where it is written: “The human being is to 
be respected and treated as a person from the moment of conception; and therefore from 
the same moment his rights as a person must be recognized, among which in the first 
place is the inviolable right of every innocent being to life.” The implication of this view 
of the fetus for Catholic teaching on abortion has long been clear: abortion is an 
abominable crime.  In Donum Vitae, however, the CDF draws out the implications of this 
view of the fetus for embryo research as well. “No objective,” the CDF writes, “can in 
any way justify experimentation on living human embryos or fetuses, whether viable or 
not, either inside or outside the mother’s womb.” Indeed, this has been the consistent 
response of the Catholic Church to every new scientific development in reproductive 
technology that involves manipulating early embryos. Whether the issue is IVF or 
embryo freezing, preimplantation genetic diagnosis or ES cell research, all are wrong—
indeed, the suggestion is that all are murderous, because all typically involve the 
destruction of a living person in the eyes of the Catholic Church.  The U.S. Roman 
Catholic Bishops oppose the research as "immoral, illegal, and unnecessary." They say 
life is sacred from the moment of conception. 
Although the Catholic Church condemns embryonic stem cell research, they do 
support some forms of research. Adult stem cell and parthenote research are both 
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accepted by the majority of Christian religions with the exception of a few radical 
factions, who view all stem cell research as “playing” God.  
  
JEWISH 
There is an emerging consensus of Reform Jewish authorities that tissue obtained 
from either therapeutic or spontaneous abortions may be used for purposes of life-saving 
or life-enhancing research and treatment.  Jewish requirements that we use our God-given 
knowledge to heal people, together with the concept of pikuach nefesh (Scheib, 2005) 
(the primary responsibility to save human life, which overrides almost all other laws) has 
been used by Jewish legal authorities to justify a broad range of organ transplants and 
medical experimentation. These requirements likewise justify the use of fetal tissue 
transplants. The Religious Action Center of Reform Judaism also approves, saying what 
would be "immoral and unethical" is cutting off funds for promising medical research. 
The Union of Orthodox Jewish Congregations agreed, saying, "an isolated fertilized egg 
does not enjoy the full status of personhood" (www.pbs.org).  Judaism also condones the 
use of adult stem cells and parthenotes in stem cell research. 
 
MUSLIM  
Embryonic stem cell research is not opposed by the Muslim religion, although 
there is still some debate as to when ensoulment occurs. Some Islamic scholars hold 
favorable views toward embryonic stem-cell research from the perspective of sharia 
(Islamic law).  Most of these scholars believe ensoulment of the embryo occurs on the 
120th day of the pregnancy (well past the 5 day old blastocyst from which ES cells are 
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isolated), and that is the point when it gains its moral status or rights as a legal person. 
Other Islamic scholars, however, say ensoulment occurs on the 40th day (also well past 5 
days).  According to another view of sharia, there is a distinction between potential life 
and actual life.  Although life begins at conception in the womb, an embryo formed by 
artificial fertilization is not in its natural environment. If it is not placed in the womb it 
will not survive and it will not become a human being.  Iranian scientists developed 
human embryonic stem-cell lines in 2003 with the approval of Ayatollah Seyed Ali 
Khamenei, Iran's supreme religious leader.  Singapore, where Muslims have a slight 
majority, has also produced embryonic stem-cell lines. And nonembryonic stem-cell 
research, using adult and umbilical stem cells is conducted in Iran, Saudi Arabia, and 
Malaysia.  In 2003, a scholar in Cairo issued a fatwa (Islamic religious ruling) stating that 
therapeutic cloning of embryos would be considered lawful and could be compared to the 
accepted practice of donating cells, tissues, or organs for transplants. 
 
HINDU 
 
Many Hindus see the soul - the true Self (or atman) - as the spiritual and 
imperishable component of human personality. After death destroys the body, the soul 
soon finds a new temporal home.  Thus, for Hindus as much as for Catholics, life begins 
at conception. The ancient system of Indian medicine known as Ayurveda assumes that 
fetuses are alive and conscious when it prescribes a particular mental and spiritual 
regimen to pregnant women.  
American scientists and businessmen note enviously that religious and moral 
considerations do not seem to inhibit Indian biotechnologists. But this indifference to 
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ethical issues would have certainly appalled Gandhi, father of the Indian nation. Gandhi 
accused Western medicine, along with much of modern science and technology, of 
inflicting violence upon human nature. His vegetarianism and belief in nonviolence were 
derived from Indian traditions, mainly Hinduism, which is also the faith, though loosely 
defined, of most Indian scientists and businessmen. 
 
WHY WE NEED ES AND EG CELLS FOR RESEARCH 
The reason that researchers need ES and EG cells is because of our lack of 
knowledge about human genetics and development. We are only beginning to understand 
the very basics of embryonic development, and such research needs to be done to 
understand how to repair developed humans. The issue socially is whether we should be 
able to use an aborted fetus for EG cell research, separate from the issue of abortion. The 
other issue is whether it is ethical to use human embryos from fertility clinics for 
research. Unused embryos from couples using IVF or other infertility procedures can be 
donated for research, donated for infertile couples, destroyed, or permanently frozen. All 
will eventually be destroyed. These “extra” embryos could be used for research that 
would benefit society as a whole, and are going to be destroyed, essentially wasted. 
Using these for research would be the logical decision, seeing that they will be used to 
benefit all humans, and are going to be destroyed.  But many people oppose the use of 
these ES cells for research. Getting these ES cells from spontaneous abortion has proven 
to be unreliable because of the specific time frame in which it must occur and the chances 
of it happening outside the hospital environment. The spontaneously aborted embryos 
also usually have genetic anomalies that prevent them from being used for research.  
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Unfortunately we are at a stage right now where we need ES cells to be able to advance 
our understanding of the human body on a genetic level, and to save lives via therapy. 
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CHAPTER 4:  STEM CELL LEGALITIES
 
 
Figure 2 Cartoon by Vic Harville 
 
Stem cell research in the U.S. has been delayed mostly due to politics.  In 2001 
President Bush declared that all government-funded research could only work with ES 
cell lines that were in existence before August 9, 2001. The decision has crippled the 
United States’ ability to conduct stem cell research. The government declared that there 
were over 60 ES cell lines available for research, when in reality there were only about 
19, as determined by subsequent genetic analysis.  President Bush also proposed a ban on 
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cloning technology. This proposal came after Advanced Cell Technology (Worcester, 
MA) announced it had successfully cloned a human embryo for research. This 
announcement magnified the misunderstanding revolving around human stem cell 
research and cloning. The words cloning and embryonic research triggered an immediate 
response from a more or less neutral uneducated government.  People hear cloning and 
think about Dolly the cloned sheep, or about scientists creating clones of people. This is a 
misconception commonly made by a large part of society. The reality of the cloning was 
that Advanced Cell Technology had cloned a human embryo for ES cell research. The 
possibility of creating a developed cloned human without problems is a long way off, and 
people do not understand the difference between that kind of cloning and cloning to 
create new ES cell lines. 
The thing that most of the people opposing stem cell research and cloning 
research are forgetting is that someone is going to do the research whether we think it is 
right or not. We, as a world power, should lead the scientific community into the 
unknown of stem cell technology.  Instead, research is halted due to all of the ethical 
issues that arise from the idea of stem cells.  Stem cell ethics and policy should be looked 
at carefully, but they should be looked at in an educated framework. Forming opinions 
about something that is unknown should be frowned upon, but popular figures in our 
society have come out condemning it without any understanding.  In order for our society 
to make a conscious, educated decision about stem cell research we must strive to 
educate everyone involved in legislative decisions.   
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STEM CELL RESEARCH IN OTHER COUNTRIES 
Although human ES cells were first isolated in the U.S., other countries have 
begun the race for stem cells, and we are having difficulty staying in the game due to our 
crippling stem cell research laws.  On July 7, 2005 the Korean government gave 
permission for stem cell research.  Seoul National University Professor Hwang Woo-suk, 
the world-renowned cloning pioneer, was already allowed to conduct his stem cell studies 
in January.  Maria Biothec head Dr. Park Se-pill is one of the leaders in creating new 
stem cell lines from frozen embryos.  He harvested 7 stem cell lines from 20 frozen 
embryos in 2004. This is an unprecedented success in harvesting stem cell lines from 
frozen human embryos.  In the Czech Republic new stem cell lines were created last year 
at the Mendel University of Agriculture and Forestry. Sweden allows stem cells to be 
harvested from unused IVF embryos. Sweden also has more than 30 research teams and 
over 300 people doing the research, setting them far ahead in the stem cell manpower. 
Researchers in Sweden have been conducting stem cell research for over 15 years now 
and have the most funding for their research. “Professor Patrik Brundin, who heads the 
section for Neuronal Survival at the Wallenberg Neuroscience Centre at Lund University, 
has been transplanting neural tissue from aborted embryos six to eight weeks old into 
patients with Parkinson's disease for more than 15 years”. 
(http://www.geocities.com/giantfideli/CellNEWS_Swedens_stem_cell_success.html) For 
this and other reasons, the Swedish have been granted a lot of private funding from 
Parkinson’s charities and private donations.  Michael J. Fox, the actor afflicted with 
Parkinson’s disease, donated  US$4.4 million to the Swedish for research developing a 
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new line of cells to specifically do research on Parkinson’s disease. The Czech Republic, 
Singapore, Israel, Sweden and Finland have all created new stem cell lines that use 
human feeder-cells rather than mouse. The advantage to this is that there is no chance of 
implanting stem cells that carry mouse born viruses. The US has one privately funded 
laboratory that has created stem cells using human feeder cells.  Susan Fisher’s California 
lab is the only lab in the US that has successfully created these cells under private 
funding from Geron Corp.  But due to the lack of federal funding in the United States we 
have fallen behind from the stem cell frontier.  The numbers below speak for themselves. 
 
 
Figure 3.  Countries Developing New Stem Cells.  Boston 
Globe http://www.boston.com/news/science/articles/2004/06/02/stem3/ 
 
In the United States we currently have 19 ES cell lines to conduct research. The rest of 
the world has begun to pass the US in stem cell technology, and the number of ES cell 
lines available for research.  Not only are we losing the stem cell race but we are also 
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losing some of the best scientists in the world to other countries. The lack of federal 
funding and the restrictions on stem cell research has caused some of the best minds in 
our country to either choose not to work with stem cells, or to move abroad where stem 
cell research is less restricted to conduct their research.  
 
PROGRESS WITHIN THE UNITED STATES 
The United States has made some progress in the past 2 years. Although there was 
little congressional activity on stem cells after the President’s decision on stem cell 
research, some Members of Congress and many patient advocacy groups continued to 
express concern that the President’s policy hinders the progress of stem cell research. 
When the approximate number of currently available stem cell lines was revised to 20 
from 60, several Members of Congress introduced bills during the spring of 2004 that 
would have required funding for human ES cell research using newer ES cell lines. On 
April 28, 2004, more than 200 Members of the House sent a letter to the President urging 
an expansion of the policy; a similar letter from the Senate followed. Former President 
Ronald Reagan’s death from Alzheimer’s disease on June 5, and former First Lady 
Nancy Reagan’s subsequent pleas to expand the policy led to significant media coverage 
during the summer of 2004. The issue of stem cell research also played a large part in the 
2004 presidential election. 
When the 109th Congress convened, several Members of Congress reintroduced 
legislation that had been introduced during prior Congresses.  Action by several States to 
authorize and fund human ES cell research created additional pressure on Congress to 
consider legislation in this area. In fact, in an effort to support State actions related to 
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human ES cell research, Representative Nancy L. Johnson introduced H.R. 1650, the 
Stem Cell Research Investment Act of 2005. The bill would allow States to issue $30 
billion worth of zero-interest bonds to fund stem cell research, giving bondholders federal 
tax credits in lieu of interest payments.  
On May 24, 2005, the House passed H.R. 810, the Stem Cell Research 
Enhancement Act of 2005, by a vote of 238 to 194. The bill, strongly opposed by the 
White House, would effectively overturn the policy established by President Bush in 
August 2001. The vote was particularly significant because included 50 Republican 
Members who voted in favor of the bill, and who were the Chairs of 7 Committees and 
13 Subcommittees.  
 The bill H.R. 810, which was passed by Congress, is the Stem Cell Research 
Enhancement Act of 2005. The bill if passed would effectively overturn the President’s 
decision on stem cell research. It Requires the Secretary of Health and Human Services to 
conduct and support research using human ES cells, and requires  the following criteria 
be met: 1) the stem cells must be derived from embryos that were created for fertility 
purposes, in excess of clinical need, and donated from in vitro fertilization clinics, 2) 
prior to consideration of embryo donation, it must be determined that the embryos would 
never be implanted in a woman and would otherwise be discarded, and 3) donation must 
be made with written informed consent and without any financial or other inducements.   
 
PUBLIC OPINIONS IN THE UNITED STATES 
 Public outcry and celebrity endorsement have put stem cells on the move again. It 
is only a matter of time before the US has to change its policies on ES cell research. 
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Many poles conducted in the US have shown public backing for ES cell research and 
funding. A recent pole conducted by Reasearch!America and PARADE sampled 1,000 
people across the country. The sample was proportionate to the country’s demographics, 
including geography, gender and ethnicity. The survey, fielded June 4–9, 2005, has a 
theoretical sampling error of ± 3.1%.  The pole resulted in the following results 
(http://www.stemcellresearchfoundation.org/WhatsNew/July_2005.htm#8\):  
Six in 10 Americans (58%) say they support using ES cells in medical research, 
according to a new national poll by Research!America and PARADE magazine. Three in 
10 (29%) are opposed. The poll asked 1,000 adults their views on ES cell research and 
the importance of maintaining U.S. leadership in research.  Results will be published in 
the July 10, 2005 issue of PARADE. 
Other key findings include: 
• Six in 10 Americans (63%) believe the U.S. should have a uniform national 
policy for medical research using ES cells.  
• Almost as many (57%) favor federal funding of ES cell research.  
• Many Americans (62%) say they are following the issue of stem cell research at 
least somewhat closely, but 37% say they are not.  
• Of those who oppose ES cell research, 57% say their opposition is based on 
religious objections.  
• Nearly half (49%) of those who identify themselves as Republicans, 71% of 
Democrats, and 53% of Independents say they support ES cell research.  
With the rest of the world beginning new stem cell research and approving embryonic 
stem cell research it is only a matter of time before the US has to change its laws 
regarding the use of embryos in stem cell research.  Public support for stem cell research 
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in our country will eventually prevail.  If we are to be the leaders of the free world then 
we must direct stem cell research in a positive direction and lead the scientific 
community in stem cell research. Given the promises and the worldwide support for the 
research the United States should proceed conducting safe, responsible, and ethical 
research in stem cells.  
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                                          CONCLUSION 
Most cells within an animal or human being are committed to fulfilling a single 
function within the body.  In contrast, stem cells are a unique and important set of cells 
that are not specialized.  Stem cells retain the ability to become some or all of the more 
than 200 different cell types in the body and thereby play a critical role in repairing 
organs and body tissues throughout life.  Although the term stem cells is often used in 
reference to these repair cells within an adult organism, a more fundamental variety of 
stem cells is found in the early stage embryo.  Embryonic stem cells may have a greater 
ability to become different types of body cells than adult stem cells.  
Stem cell research has been the target of many recent ethical debates, mainly 
because of the controversy over how they are derived. In August 2001, President Bush 
announced that for the first time federal funds would be used to support research on 
human embryonic stem cells, but funding would be limited to “existing stem cell lines.” 
The National Institutes of Health (NIH) has established the Human Embryonic Stem Cell 
Registry, which lists 78 stem cell lines that are eligible for use in federally funded 
research.  However, only 19 embryonic stem cell lines are currently available. Scientists 
are concerned about the quality and longevity of these stem cell lines.  For a variety of 
reasons, many believe research advancement requires new embryonic stem cell lines, and 
for certain applications, stem cells derived from cloned embryos may offer the best hope 
for progress in understanding and treating disease. A significant number of pro-life 
advocates support stem cell research arguing that saving the life of a real person takes 
precedence over a blastocyst that only has the potential to become a human.  Those 
 52 
opposed are concerned that the isolation of stem cells requires the destruction of 
embryos. 
Misconception and ignorance have restricted stem cell research in the United 
States.  Our policy makers and our general population need to become educated in order 
to make the right decision about stem cell research.  Religion and state should be 
separated once again, and our policy makers should start listening to the people. Without 
federal funding and public backing for stem cells, we are going to delay what is 
eventually going to be realized as a major medical revolution.  
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